Recall Register

Drug recall: Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals Inc. East…

Class II FDA enforcement event 91171. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Subpotent Drug

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Heritage Pharmaceuticals Inc started this drug recall on 23 Nov 2022. The firm address in the FDA record is in East Brunswick, NJ. FDA put the recall in Class II. FDA event 91171 has 1 product record. The first FDA enforcement report date is 7 Dec 2022. The record gives the status Terminated, with the termination date 13 Dec 2023. 107 of the 325 drug events that started in 2022 have more product records. The median drug event of 2022 has 1 product record. The openFDA file has 325 drug events that started in 2022 and 299 that started in 2021.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide within the United States

Recalling firm

Heritage Pharmaceuticals Inc, East Brunswick, NJ.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 91171: product records
Recall numberProductQuantityClassStatusReport date
D-0072-2023Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals Inc. East Brunswick, NJ 08816, NDC 23155-490-0113805 Bottles each containing 100 tabletsClass IITerminated7 Dec 2022

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2022
325
Share of these events in Class II
65%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
12

Other events of the firm

Other FDA enforcement events of Heritage Pharmaceuticals Inc
InitiatedProduct (first record)TypeClassRecords
30 Jul 2026CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet PharmaceutDrugClass II1
6 Oct 2025Desipramine Hydrochloride Tablets, USP, 10 mg, 100 - count bottle (NDC 23155-578-01), Rx only, Manufactured by: USV PrivDrugClass II6
21 Apr 2021Acyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 0881DrugClass III1
23 Oct 2020Felodipine Extended Release Tablets, USP 10 mg,100-count bottle, Rx only, Distributed by: Heritage Pharmaceuticals Inc. DrugClass III1
21 May 2019PROCHLORPERAZINE EDISYLATE INJECTION, USP 10 mg/2mL (5mg/mL), 2mL Vial, Rx Only, Mfg by: Emcure Pharmaceuticals Ltd., HiDrugClass I2
3 May 2019Losartan Potassium Tablets, USP 50 mg 1000 film coated tablets Rx Only Manufactured by: Vivimed Life Sciences Private LiDrugClass II5
15 Feb 2019Etomidate Injection, USP 20 mg/10mL (2mg/mL) 10 mL Single-Dose Vial, Rx only, Manufactured for: Heritage PharmaceuticalsDrugClass II1
2 Jan 2019Cidofovir Injection 375mg/5mL (75mg/mL) vial injection. 5 mL vials, Rx only, Mfd by: Emcure Pharmaceuticals Ltd., HinjawDrugClass II1
15 Oct 2018Cidofovir injection 375 mg/mL (75 mg/mL) vial Injection, 5 mL vials, Rx Only, Mfg. By Emcure Pharmaceutical Ltd HinjawadDrugClass II1
25 Mar 2015GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets, USP, 2.5 mg/500 mg, 100 ct Bottles, Rx Only. Manufactured for: Heritage PDrugClass II1

Heritage Pharmaceuticals Inc: all 12 events

Official channels

Cite this page

Recall Register. FDA enforcement event 91171. https://recallregister.com/fda/ii/91171/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide within the United States
What quantity of product is in FDA event 91171?
The FDA record gives this quantity: 13805 Bottles each containing 100 tablets
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2022 have the same class?
65% of the 325 drug events that started in 2022 are in Class II.